Biosimilars

Biosimilar medicines may provide cost savings for patients who can benefit from biologic medicines. By potentially providing more affordable options, biosimilar medicines can allow for the reallocation of resources to other areas of patient care. Sensitivity of Biosimilars is high i.e. the temperature plays a big role in their maintenance. Hence, they have to be distributed through a cold chain network. 2. Their development costs are much more as compared to the generic drugs.

Biosimilars are also used to treat other medical conditions. For example, adalimumab (Humira) is used to treat conditions including arthritis, Crohn's disease and ulcerative colitis. Biosimilars for this drug include Imraldi, Amgevita, Hyrimoz, Idacio, and Yuflyma. For equal efficacy and safety, biosimilar drugs require much less research and development than their reference biologics, since they are a very similar copy. This means they are much cheaper to produce. The money saved can be reinvested.

    Related Conference of Biosimilars

    July 21-22, 2025

    11th International Conference on Antimicrobials & Antibiotic Resistance

    Vancouver, Canada
    July 21-22, 2025

    28th World Congress on Nursing, Pharmacology and Healthcare

    Barcelona, Spain
    July 24-25, 2025

    5th World Congress on Cardiovascular Medicine Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    August 21-22, 2025

    5th International Conference on Pharmaceutical Chemistry

    Dublin, Ireland
    August 25-26, 2025

    11th International Conference on Pharmaceutical Regulatory Affairs and IPR

    Vancouver, Canada
    September 08-09, 2025

    26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems

    Frankfurt, Germany
    September 08-09, 2025

    13th International Conference and Exhibition on Natural Products and Medicinal Plants Research

    Frankfurt, Germany
    September 15-16, 2025

    42nd International Conference on Drug Discovery and Drug delivery system

    Paris, France
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 22-23, 2025

    20th International Conference on Pharmaceutical Formulations & Drug Delivery

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 16-17, 2025

    18th International Conference on Pharmaceutics and Drug Safety

    Berlin,
    October 22-23, 2025

    7th European Conference on Advance Clinical Trials and Research

    Paris, France
    November 13-14, 2025

    28th International Conference and Exhibition on Pharmaceutical Formulations

    Paris, France
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    January 28-29, 2026

    23rd International Pharmaceutical Sciences & Life Saving Drugs

    Bangkok, Thailand
    February 23-24, 2026

    17th Global Pharmacovigilance & Clinical Trials Summit

    London, UK
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands

    Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in